Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Fallopian Tube Neoplasms × Erlotinib Hydrochloride × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Pancreatic Neoplasms 2 Lung Neoplasms 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Papillary renal cell carcinoma, sporadic 1 Pancreatic Intraductal Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hereditary leiomyomatosis and renal cell cancer 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Adult Solid Neoplasm 1

Interventions

Paclitaxel 16 Carboplatin 16 Bevacizumab 15 olaparib 13 Specimen Handling 12 Taxes 10 Magnetic Resonance Spectroscopy 10 Biopsy 8 liposomal doxorubicin 7 Gemcitabine 6 pembrolizumab 5 mirvetuximab soravtansine 5 Immunoglobulin G 5 Disulfides 5 niraparib 4 cediranib 4 Doxorubicin 4 Cisplatin 4 Platinum 3 Drug Therapy 3 Docetaxel 3 130-nm albumin-bound paclitaxel 3 atezolizumab 2 adavosertib 2 X-Rays 2 Topotecan 2 Standard of Care 2 Injections 2 Hyperthermic Intraperitoneal Chemotherapy 2 Aspirin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡